Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report
Rathod, D.; Weinberg, J.M..; Yamauchi, P.S..; Kircik, L.H..; Wollina, U.; Lotti, T.; Goldust, M.
Journal of Drugs in Dermatology Jdd 18(4): 394-396
2019
ISSN/ISBN: 1545-9616 PMID: 31017383 Document Number: 699752
Copy: A number of biologics have been approved for use in plaque-type psoriasis. They act by either blocking the action of a specific type of cell or protein in the immune system.
Document emailed within 1 workday
Related Documents
Zaghi, D.; Krueger, G.G.; Callis Duffin, K. 2012: Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 11(2): 160-167Danesh, M.J.; Beroukhim, K.; Nguyen, C.; Levin, E.; Koo, J. 2015: Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasis Dermatology Online Journal 21(6)
Bandinelli, F.; Bonacci, E.; Matucci-Cerinic, M. 2013: Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment Clinical and Experimental Rheumatology 31(3): 440-442
Bravo, E.A.; Carrion, L.; Paucar, S.M.; Mendoza, R.; Rivera, C. 2014: Successful treatment of pityriasis rubra pilaris with adalimumab - case report Dermatology Online Journal 20(4): 22374
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Kampitak, T.; Asawanonda, P. 2006: The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study Journal of the Medical Association of Thailand 89(Suppl 3): S20-S24
Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756
Ardigò, M.; Giuliani, A.; de Felice, C.; Mastroianni, A.; Berardesca, E. 2008: Efficacy of adalimumab in plaque psoriasis: experience on 28 patients Journal of Drugs in Dermatology: Jdd 7(10): 935-939
Wu, J.J.; Valdecantos, W.C. 2017: Adalimumab in Chronic Plaque Psoriasis: a Clinical Guide Journal of Drugs in Dermatology: Jdd 16(8): 779-790
Bhatia, N.; Kircik, L. 2018: Clobetasol Emulsion Foam and Calcipotriene 0.005% Foam Combination Therapy for the Maintenance of Treatment Response in Patients with Moderate Plaque Psoriasis Journal of Drugs in Dermatology: Jdd 17(3): 342-346
Vender, R. 2011: An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab Journal of Drugs in Dermatology: Jdd 10(4): 396-402
Lythgoe, M.; Abraham, S. 2016: Tacrolimus: an effective treatment in refractory psoriatic arthritis following biologic failure Clinical and Experimental Rheumatology 34(1 Suppl 95: S12-S13
Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Forman, S.B.; Higginson, R.; Garrett, A.B. 2008: Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment Journal of Drugs in Dermatology: Jdd 7(10): 972-973
Doolan, B.J.; Cranwell, W.C.; Nicolopoulos, J.; Dolianitis, C. 2019: Secondary organizing pneumonia (bronchiolitis obliterans with organizing pneumonia) associated with adalimumab for treatment of chronic plaque psoriasis Dermatology Online Journal 25(10)
Gupta, A.K.; Cernea, M.; Lynde, C.W. 2017: Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis Skin Therapy Letter 22(2): 1-7
Segaert, S.; Ropke, M. 2013: The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis Journal of Drugs in Dermatology: Jdd 12(8): E129-E137
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942
Kamangar, F.; Berger, T.G.; Fazel, N.; Koo, J.Y.M. 2013: Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report Cutis 92(3): 148-150
Serirat, O. 2014: Observational cases report of a group of severe plaque type psoriasis patients treated with ustekinumab Journal of the Medical Association of Thailand 97 Suppl. 11: S150-S153